600056 中國醫藥
按盤價 
11.720 -0.590 (-4.793%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 26,099,730 | -12.41% | 38,824,431 | 37,592,650 | 36,234,415 | 39,311,753 | |
| 減：營業總成本 | 25,216,784 | -12.09% | 37,501,895 | 36,137,940 | 34,480,964 | 36,386,460 | |
| 其中:營業成本 | 23,317,059 | -12.00% | 34,440,814 | 32,845,786 | 31,018,239 | 32,512,228 | |
| 財務費用 | 127,562 | 89.74% | 112,038 | 138,317 | 221,691 | 257,359 | |
| 資產減值損失 | 1,150 | -74.02% | (13,539) | (280,660) | (575,297) | (682,774) | |
| 公允價值變動收益 | (1,109) | -431.63% | 985 | 1,922 | (2,135) | 656 | |
| 投資收益 | 5,003 | -82.02% | (15,792) | 51,001 | 43,657 | 37,514 | |
| 其中：對聯營企業和合營企業的投資收益 | 35,149 | -46.51% | 77,043 | 93,219 | 113,900 | 88,306 | |
| 營業利潤 | 850,565 | -23.06% | 1,672,334 | 1,199,698 | 937,135 | 1,939,187 | |
| 利潤總額 | 842,784 | -24.02% | 1,640,556 | 1,196,127 | 940,106 | 1,925,266 | |
| 減：所得稅費用 | 221,866 | -31.84% | 398,435 | 307,699 | 225,830 | 539,186 | |
| 淨利潤 | 620,918 | -20.77% | 1,242,120 | 888,428 | 714,276 | 1,386,081 | |
| 減：非控股權益 | 173,770 | -8.33% | 194,081 | 152,827 | 67,219 | 75,435 | |
| 股東淨利潤 | 447,148 | -24.74% | 1,048,039 | 735,601 | 647,057 | 1,310,646 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.299 | -24.75% | 0.701 | 0.492 | 0.433 | 1.227 | |
| 每股派息 (元) * | 0.022 | -- | 0.210 | 0.148 | 0.182 | 0.368 | |
| 每股淨資產 (元) * | 7.793 | 4.18% | 7.728 | 7.230 | -- | 9.364 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | -- | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 22/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
